Results 251 to 260 of about 400,342 (335)

Aurora-A inhibits hepatocellular carcinoma cell ferroptosis to mediate immune escape by disrupting phosphatidylethanolamine biosynthesis. [PDF]

Am J Cancer Res
Fan L, Liu Y, Cai Y, Sun X, Li J, Xu Y, Sun C, Cui S.   +7 more
europepmc   +1 more source

Focal adhesion signaling in hepatocellular carcinoma (HCC): A mechanism of apoptosis

, 2003
Carol P.R. Bowen, Joshua D. Rovin, Kevin B. Thorne, Reid B. Adams   +3 more
openalex   +1 more source

Lactylation in cancer biology: Unlocking new avenues for research and therapy

Cancer Communications, EarlyView.
Abstract Lactylation, a newly identified post‐translational modification, plays a multifaceted role in cancer biology by integrating epigenetic and non‐epigenetic mechanisms. This review summarizes the latest research progress on lactylation, including its functions in epigenetic regulation and its broader impact on cellular processes.
Xiaoyu Hou, Zhenya Hong, Huimin Zen, Changyi Zhang, Peng Zhang, Ding Ma, Zhiqiang Han   +6 more
wiley   +1 more source

The causes of mortality in patients with hepatocellular carcinoma are different between hepatitis B virus-related and hepatitis C virus-related Hcc

, 2003
Yoshiyuki Kobayashi, Nobuyuki Toshikuni, Shinichiro Nakamura, Eiji Matsumoto, Hironori Tanaka, Kazuhiro Nouso, Kohsaku Sakaguchi, Yasushi Shiratori, Yasuyuki Araki, Hiroshi Ikeda, Mitsuhiko Kawaguchi, Haruhiko Kobashi   +11 more
openalex   +1 more source

Electrocatalytic CO2 Reduction to Multi‐Carbon Products on Non‐Copper‐Based Catalysts: Reaction Pathways, Enhancement Strategies, and Future Challenges

Carbon and Hydrogen, EarlyView.
We systematically analyze the main reaction pathways leading to C2+ ${\mathrm{C}}_{{2}^{+}}$ products, including ethylene formation and higher hydrocarbon (C2–4) alcohols and oxygenates, while critically assessing the mechanistic insights that differentiate non‐copper catalysts from their Cu‐based counterparts.
Nida Rehman, Yilin Wang, Xinyi Tan, Xinyi Fan, Xueying Li, Wancai Shi, Alex W. Robertson, John Texter, Ume Aiman, Zhenyu Sun   +9 more
wiley   +1 more source

FBXW11 inhibits tumorigenesis by ubiquitinating YB1 in hepatocarcinoma. [PDF]

J Cancer Res Clin Oncol
Liu W, Xu B, Wang T, Liu X, Dong C, Wang L.   +5 more
europepmc   +1 more source

UNOS Liver-Transplant Policy Being Revised To Give HCC Patients Lower Priority

, 2003
Peggy Eastman
openalex   +1 more source

Rodent monocyte‐derived macrophages do not express CD163: Comparative analysis using macrophages from living boreoeutherians

Developmental Dynamics, EarlyView.
Abstract Background CD163 is a scavenger receptor predominantly expressed on the surfaces of macrophages in various mammalian species and is a marker of anti‐inflammatory (M2‐like) macrophages. High density of CD163‐positive tumor‐associated macrophages (TAMs) is associated with worse prognosis in various patient tumors.
Yoichi Saito, Yukio Fujiwara, Yasuka L. Yamaguchi, Satomi S. Tanaka, Kyoko Miura, Yoshiyuki Hizukuri, Kyoko Yamashiro, Yasuhiro Hayashi, Yuta Nakashima, Yoshihiro Komohara   +9 more
wiley   +1 more source

Targeting phase separation: a promising treatment option for hepatocellular carcinoma. [PDF]

Cell Commun Signal
Zhou Z, Jin S, Li X, Zhang D, Zhang S, Zhou H, Cai J, Song T, Wang X, Kong Q, Tang Z, Tan J, Zhang J.   +12 more
europepmc   +1 more source

Intra-Arterial Delivery System Localizes Treatment of HCC

, 2003
Paula Moyer
openalex   +1 more source